Related Experiment Videos
Anemia and heart failure
1Harper University Hospital, 3990 John R Street, 9 Webber Core, Detroit, MI 48201, USA. jghali@dmc.org
Purpose Of Review:
The earlier enthusiasm for raising hemoglobin in heart failure has been followed by skepticism and concern of potential harm from using erythropoiesis-stimulating agents (ESAs).
Recent Findings:
Several recent studies have confirmed the high prevalence and prognostic role of anemia and have shown encouraging signals of the safety of using ESAs in heart failure and potential benefit that may be related to nonhematopoietic effects of ESAs. In addition, recent studies have also suggested a potential beneficial role of iron replacement in heart failure.
Summary:
Despite the encouraging findings of these preliminary studies, the future role of ESAs and iron replacement will be determined by ongoing randomized placebo-controlled studies.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Heart Failure II: Pathophysiology